BSE filing, NSE: COROMANDEL. Summary written from the filing by ALFA Finder's alert engine.
Coromandel International Ltd: key numbers
- Share price
- ₹1,703.50
- Market cap
- ₹50,264 Cr
- Revenue (annual)
- ₹31,480 Cr
- Net profit (annual)
- ₹1,956 Cr
- P/E (TTM)
- 27.4×Sector 9.6×
- Promoter holding
- 56.34%-0.01% QoQ
- FII holding
- 11.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Coromandel International Ltd
All →Coromandel International Legal & Regulatory
Coromandel International received a Deputy Commissioner (Appeal) GST order-in-appeal for FY 2019-20 confirming ineligible input tax credit demand. The company will appeal before GSTAT and expects no significant financial impact.
- Value
- ₹0.18 Cr
Coromandel International Legal & Regulatory
Coromandel International received a GST Order-in-Appeal confirming a ₹1.79 Crore tax demand. Including interest and penalty, the total is ₹4.05 Crore; the company will appeal.
- Value
- ₹4.05 Cr
Coromandel International Legal & Regulatory
Coromandel International received a Rs 2.51 Crore GST demand order from Vadodara tax authorities over ITC. The company will appeal and expects no significant financial impact.
- Value
- ₹2.51 Cr
Coromandel International Other Announcement
Coromandel International Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Coromandel International Legal & Regulatory
Coromandel International received a GST order-in-appeal for FY 2019-20, demanding Rs. 0.84 Crore including tax and penalty. The company plans to file an appeal.
- Value
- ₹0.84 Cr
Coromandel International Debt & Borrowing: ₹147.2 Cr
Coromandel International issued a USD 15.5 million corporate guarantee to Citibank N.A. for its subsidiary, Baobab Mining & Chemicals Corporation, Senegal, to secure working capital.
- Value
- ₹147.2 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date